Carisma Therapeutics Inc. ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Steven Kelly, President and Chief Executive Officer, will participate in the ...
JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR") announced today that it will present at the 21st Annual WORLDSymposiumtm 2025, held February 3-7, 2025, in San Diego, Calif. The poster presentations ...
Zevra to receive a 2025 New Treatment Award for MIPLYFFAâ„¢ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...
The global enzyme replacement therapy market size was valued at USD 10.12 billion in 2024 and is projected to grow from USD 11.35 billion in 2025 to reach USD 21.29 billion by 2033, exhibiting a CAGR ...
Julien Grogg, PhD, MBA - CEO of Release Therapeutics Release Tx logo Dr. Julien Grogg will Lead the Company's Transition to Clinical ...
Immusoft Corporation, a cell therapy company dedicated to improving the lives of patients with rare diseases, today announced that it will feature oral and poster presentations at the upcoming ...
In 2017, neurologists at New York Presbyterian/ Columbia University’s movement clinic diagnosed Daniel with Niemann-Pick disease Type C (NPC): a lysosomal storage disorder caused by NPC1 mutations.
Our work extends the application of this motif to enzymes specific to the lysosomal compartment and relevant to genetic diseases affecting ... of correction for storage pathology in the spleen ...
NIMHANS hosts ISHG meet to foster innovation for domestic and global healthcare solutions: Our Bureau, Bengaluru Tuesday, January 21, 2025, 10:00 Hrs [IST] National Institute of M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback